I'm A Patient
I'm A Provider
As an eye doctor, delivering a dry age-related macular degeneration (AMD) diagnosis is one of the most difficult conversations we have. For years, our main goal has been to preserve the sight you have. We’ve focused on slowing the progression of the disease, but that still leaves many people worried about the future of their vision.
The conversation around dry AMD treatment is changing. While every person’s experience is unique, MacuMira is a treatment designed to improve visual function. It represents a new approach that offers a way to actively support retinal health.
A New Path for Dry Age-Related Macular Degeneration Treatment
Dry AMD can cast a shadow over daily life, affecting your independence and peace of mind. Common activities, like reading a book or recognising a loved one’s face, can become a challenge. The introduction of a new treatment for age-related macular degeneration shifts our focus from just managing decline to actively pursuing improvement.
The Impact of Dry AMD on Daily Life
Living with dry AMD often means adjusting to a world that’s less clear. This progressive eye condition is a common cause of vision loss for adults over 50. MacuMira provides a different way to approach care for this condition.
A Shift from Vision Preservation to Improvement
Instead of only focusing on slowing down vision loss, this therapy is designed to help improve retinal function. It gives people with dry AMD and their eye doctors a new option to consider. This marks a significant step forward in how we manage the condition.
What Is MacuMira and How Does It Work?
MacuMira is a non-invasive therapy for those affected by dry AMD. It uses a specific microcurrent to stimulate the retina in a simple and comfortable process. This supports your macular health by helping your retinal cells function more effectively.
Use Microcurrents to Stimulate Your Retina
The treatment sends a gentle microcurrent through your closed eyelids. This process encourages better function in the retinal cells at the back of your eye. The goal is to help these cells produce the energy they need, which may lead to improved vision.
A Non-Invasive and Drug-Free Approach
The MacuMira treatment process is straightforward and comfortable. There are no injections, medications, or surgery involved. It’s a relaxing experience that allows you to rest while the device does its work. You can find more details in our frequently asked questions for patients.
How MacuMira Fits Into Your Eye Care Plan
MacuMira can easily be added to an existing dry age-related macular degeneration treatment plan. Eye care professionals may use it alongside other supportive strategies, such as:
- Nutritional supplements
- Lifestyle adjustments
- Visual aids
The MacuMira Treatment Process Explained
A MacuMira session is designed to be simple and comfortable. There is no downtime, so you can get back to your day right after the appointment. Here’s a look at what you can expect.
Prepare for Your Session
You’ll sit in a comfortable chair while an eye care professional places small electrode pads on your head. They will explain each step of the process. This helps you feel informed and at ease before you begin.
What to Expect During the 32-Minute Treatment
For about 32 minutes, you will relax with your eyes closed as the device delivers a gentle microcurrent. Many people choose to listen to music or an audiobook during this time. You may feel mild pressure, but the process is not painful.
Your Treatment Schedule: Initial and Maintenance
The treatment plan begins with an initial phase, followed by regular maintenance to support your results.
- Initial phase: Four 32-minute treatments over approximately 10 days.
- Maintenance phase: One treatment every 3 months to help maintain visual improvements.
Real Results and Patient Stories
Clinical data and personal stories show the potential of MacuMira as a dry AMD treatment. Many people report noticeable changes in their vision. This often comes with a renewed sense of freedom in their daily lives.
What the Clinical Data Suggests
Results from a clinical trial for MacuMira were positive. Some key findings include:
- 48% of participants improved by 10 or more letters on a standard vision chart.
- The average improvement was 8.2 letters—a 25% increase in visual sharpness.
- No adverse side effects were noted during the trial.
Hear From People Who Chose MacuMira
The people who have received the treatment often share powerful experiences. Common feedback includes clearer and brighter vision, as well as greater independence.
Results vary from person to person, and not everyone will notice the same level of improvement. MacuMira is designed to support visual function, complementing your overall eye care plan.
Could MacuMira Work for You or Your Patients?
MacuMira offers a new path for those with dry AMD at various stages. It provides a new tool for eye care professionals to support their patients.
Who Is a Good Candidate for This Treatment?
This dry AMD treatment may be a suitable option if you or your patients:
- Have a diagnosis of dry AMD.
- Want to explore a non-invasive way to manage the condition.
- Value a complete eye health plan that includes modern therapies.
Discuss MacuMira with an Eye Doctor
An initial consultation with an eye care provider offering MacuMira is the first step. They can evaluate the stage of dry AMD and overall eye health. This helps determine if MacuMira is the right choice for your vision goals.
The way we approach dry AMD is evolving, and it’s an exciting time for both eye doctors and the people we serve. MacuMira offers a new way to support visual function and improve quality of life. To learn more about how this treatment could help you or your patients, speak with an eye care professional offering MacuMira today.
